17, the FDA issued warning letters to four companies that were selling multiple GLP-1 products for sale, including forms of drugs that have not yet been FDA approved such as retatrutide (Eli Lilly), CagriSema (Novo Nordisk) and survodutide (Boehringer Ingelheim/Zealand Pharma)
doi: 10.1016/S0008-6363(00)00097-3 118 RobertsLJMorrowJD
Helpful Daily Checklist Get a focused daily list based on your tracking routine, so you can remember key actions like logging your dose, checking hydration, tracking protein, recording symptoms, and reviewing progress
However, high-dose niacin (as a medication for cholesterol) is generally not recommended during breastfeeding, because significant amounts could enter milk and cause unwanted effects in the nursing infant (flushing, for example)
Monthly Provider Re-Review Your provider evaluates: Weight progress Side effects Dose response Refill eligibility Dose Titration Dose adjustments follow the standard GLP-1 titration schedule based on: Weight loss progress Tolerability Side effect profile Unlimited Secure Messaging Ask questions anytime Care team responds within 4 business hours Side Effect Escalation Concerning symptoms are escalated directly to your provider for urgent review
